Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | AXL | P30530 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | APAF1 | O14727 | 1/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.33 |
| ▸ | CASP3 | P42574 | 1/20 | 0.33 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1590024 | 0.82 | ALDH1A1 (0.42) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| SCHEMBL29384787 | 0.82 | CYP3A4 (0.62) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| SCHEMBL33944 | 0.82 | CYP3A4 (0.62) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| SCHEMBL29380074 | 0.82 | ALDH1A1 (0.42) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| SCHEMBL29901155 | 0.81 | ALDH1A1 (0.39) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| SCHEMBL30238695 | 0.81 | ALDH1A1 (0.42) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| SCHEMBL145182 | 0.81 | ALDH1A1 (0.39) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| SCHEMBL2319989 | 0.81 | ALDH1A1 (0.39) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| SCHEMBL767268 | 0.79 | ALDH1A1 (0.44) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL529931 | 0.78 | CYP3A4 (0.59) | CYP3A4TSHRPIK3CAALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116813610-B | Selenophene-containing cycloindole sulfonate inner salt and preparation method and application thereof | 德州学院 | 2023-11-21 | — | — | CN | claimed |
| CN-116813610-A | Selenophene-containing cycloindole sulfonate inner salt and preparation method and application thereof | 德州学院 | 2023-09-29 | — | — | CN | claimed |
| EP-1086185-A1 | ADHESIVE FORMULATIONS | Lord Corporation (US) | 2001-03-28 | — | — | EP | claimed |
| WO-1999064529-A1 | ADHESIVE FORMULATIONS | LORD CORPORATION (US) | 1999-12-16 | — | — | WO | claimed |
| EP-0558857-A1 | Method for the manufacture of P-bromodimethyl aniline | IMI (TAMI) INSTITUTE FOR RESEARCH & DEVELOPMENT LTD. (IL) | 1993-09-08 | — | — | EP | claimed |
| US-4983754-A | Method for the manufacture of dimethyl, octyl - or pentyl - para-aminobenzoic acid | BROMINE COMPOUNDS LTD. (IL) | 1991-01-08 | — | — | US | claimed |
| JP-5221932-A | — | — | None | — | — | JP | disclosed |
| JP-7179463-A | — | — | None | — | — | JP | disclosed |
| US-20250171417-A1 | HETEROCYCLIC DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF | XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) | 2025-05-29 | — | — | US | disclosed |
| EP-4524139-A1 | IMIDAZOPYRIDAZINE SUBSTITUTED BENZENE RING DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE | Shanghai Simr Biotechnology Co., Ltd. (CN) | 2025-03-19 | — | — | EP | disclosed |
| CN-119638639-A | Biaryl compound with anti-cell necrotic apoptosis activity, derivative and application thereof | 中国药科大学 | 2025-03-18 | — | — | CN | disclosed |
| WO-2025049824-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | OSMO LABS, PBC (US) | 2025-03-06 | — | — | WO | disclosed |
| EP-3105202-B1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | BASF SE (DE) | 2024-11-13 | — | — | EP | disclosed |
| EP-0116974-A1 | 11-Beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1984-08-29 | — | — | EP | disclosed |
| US-4341894-A | 2,4,6 TRI-SUBSTITUTED PYRYLIUM DYE SALTS | EASTMAN KODAK COMPANY (US) | 1982-07-27 | — | — | US | disclosed |
| US-4167412-A | COMPRISING A PYRYLIUM OR THIOPYRYLIUM SALT | EASTMAN KODAK COMPANY (US) | 1979-09-11 | — | — | US | disclosed |
| US-4113497-A | COMPOSITIONS WITH ORGANOHALOGEN COMPOUND AND DIAZONIUM SALTS AS PHOTOINITIATORS OF EPOXY COMPOUNDS IN PHOTO-POLYMERIZATION | AMERICAN CAN COMPANY (US) | 1978-09-12 | — | — | US | disclosed |
| US-3988152-A | Epoxy resin photoresist with iodoform and bismuth triphenyl | AMERICAN CAN COMPANY (US) | 1976-10-26 | — | — | US | disclosed |
| US-3977878-A | Epoxy resin photoresist with iodoform and bismuth triphenyl | AMERICAN CAN COMPANY (US) | 1976-08-31 | — | — | US | disclosed |
| US-3977874-A | CATIONIC CATALYST, PHOTOPOLYMERIZATION | AMERICAN CAN COMPANY (US) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250171417-A1 | HETEROCYCLIC DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF | AR, BCKDK, CYP11B2 | CYP3A4 144/4885TSHR 3687/4885PIK3CA 1972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.